MX350719B - Bakuchiol compositions for treatment of post inflammatory hyperpigmentation. - Google Patents
Bakuchiol compositions for treatment of post inflammatory hyperpigmentation.Info
- Publication number
- MX350719B MX350719B MX2013008890A MX2013008890A MX350719B MX 350719 B MX350719 B MX 350719B MX 2013008890 A MX2013008890 A MX 2013008890A MX 2013008890 A MX2013008890 A MX 2013008890A MX 350719 B MX350719 B MX 350719B
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- inflammatory hyperpigmentation
- bakuchiol
- post inflammatory
- disclosed
- Prior art date
Links
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 title abstract 3
- 206010036229 Post inflammatory pigmentation change Diseases 0.000 title abstract 3
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 title abstract 3
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 title abstract 3
- 229940117895 bakuchiol Drugs 0.000 title abstract 3
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000012641 Pigmentation disease Diseases 0.000 abstract 1
- 230000019612 pigmentation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Methods for treating excess pigmentation, including treatment of post inflammatory hyperpigmentation (PIH), are disclosed. The disclosed methods comprise administration of a composition comprising bakuchiol substantially free of furanocoumarins to a mammal. Compositions comprising bakuchiol and methods for their preparation are also disclosed.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161438890P | 2011-02-02 | 2011-02-02 | |
| PCT/US2011/026594 WO2012105990A1 (en) | 2011-02-02 | 2011-03-01 | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation |
| PCT/US2012/023686 WO2012106551A1 (en) | 2011-02-02 | 2012-02-02 | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013008890A MX2013008890A (en) | 2013-10-17 |
| MX350719B true MX350719B (en) | 2017-09-14 |
Family
ID=46603028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013008890A MX350719B (en) | 2011-02-02 | 2012-02-02 | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation. |
Country Status (8)
| Country | Link |
|---|---|
| KR (5) | KR102156731B1 (en) |
| CN (2) | CN103458882B (en) |
| AU (1) | AU2012212153B9 (en) |
| BR (1) | BR112013019798A2 (en) |
| CA (4) | CA3128711A1 (en) |
| HK (1) | HK1215792A1 (en) |
| MX (1) | MX350719B (en) |
| WO (1) | WO2012105990A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10471035B2 (en) | 2014-10-20 | 2019-11-12 | Sunny BioDiscovery | Compositions and methods for using esters of meroterpenes and of other resveratrol analogues |
| CN105675741A (en) * | 2015-12-30 | 2016-06-15 | 成都九芝堂金鼎药业有限公司 | Method for determining content of effective components in hair growing pill |
| KR20190116858A (en) | 2018-04-05 | 2019-10-15 | 주식회사 엑소코바이오 | A composition comprising an exosome and/or extracellular vesicle derived from stem cell as an active ingredient and its application for preventing, alleviating, reducing or removing postinflammatory hyperpigmentation |
| CN111544317B (en) * | 2020-04-29 | 2022-01-14 | 珀莱雅化妆品股份有限公司 | Anti-aging composition cationic nano-liposome and preparation method and application thereof |
| CN114478196B (en) * | 2021-01-27 | 2023-11-10 | 江苏巴帝恩生物科技有限公司 | Method for extracting and purifying bakuchiol from Ulmus pumila root and application of bakuchiol in cosmetics |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2617473B2 (en) | 1987-06-30 | 1997-06-04 | キヤノン株式会社 | Information input device |
| KR101802415B1 (en) * | 2005-05-09 | 2017-11-28 | 유니젠, 인크. | Compositions of bakuchiol and methods of making the same |
| WO2008140673A1 (en) * | 2007-05-14 | 2008-11-20 | Sytheon Ltd. | Skin treatment compositions and methods |
-
2011
- 2011-03-01 WO PCT/US2011/026594 patent/WO2012105990A1/en active Application Filing
-
2012
- 2012-02-02 KR KR1020197005663A patent/KR102156731B1/en active IP Right Grant
- 2012-02-02 CA CA3128711A patent/CA3128711A1/en active Pending
- 2012-02-02 KR KR1020217038833A patent/KR102525516B1/en active IP Right Grant
- 2012-02-02 BR BR112013019798A patent/BR112013019798A2/en not_active Application Discontinuation
- 2012-02-02 CN CN201280015007.XA patent/CN103458882B/en active Active
- 2012-02-02 CN CN201510390680.7A patent/CN105147533B/en active Active
- 2012-02-02 CA CA3128718A patent/CA3128718A1/en active Pending
- 2012-02-02 KR KR1020237013482A patent/KR102642352B1/en active IP Right Grant
- 2012-02-02 KR KR1020137022953A patent/KR101954118B1/en active IP Right Grant
- 2012-02-02 MX MX2013008890A patent/MX350719B/en active IP Right Grant
- 2012-02-02 CA CA2826262A patent/CA2826262C/en active Active
- 2012-02-02 KR KR1020207026173A patent/KR102333655B1/en active IP Right Grant
- 2012-02-02 AU AU2012212153A patent/AU2012212153B9/en active Active
- 2012-02-02 CA CA3128715A patent/CA3128715A1/en active Pending
-
2016
- 2016-04-01 HK HK16103749.0A patent/HK1215792A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN105147533A (en) | 2015-12-16 |
| HK1215792A1 (en) | 2016-09-15 |
| CA3128715A1 (en) | 2012-08-09 |
| KR20230058727A (en) | 2023-05-03 |
| MX2013008890A (en) | 2013-10-17 |
| KR20200108120A (en) | 2020-09-16 |
| CA3128711A1 (en) | 2012-08-09 |
| BR112013019798A2 (en) | 2017-07-04 |
| CA2826262C (en) | 2021-10-26 |
| KR102525516B1 (en) | 2023-04-24 |
| AU2012212153B9 (en) | 2017-05-11 |
| AU2012212153A1 (en) | 2013-08-29 |
| CA3128718A1 (en) | 2012-08-09 |
| KR20140008364A (en) | 2014-01-21 |
| KR20210145864A (en) | 2021-12-02 |
| KR102333655B1 (en) | 2021-12-01 |
| CN103458882A (en) | 2013-12-18 |
| AU2012212153B2 (en) | 2017-04-06 |
| KR102642352B1 (en) | 2024-02-28 |
| CN103458882B (en) | 2015-08-05 |
| WO2012105990A1 (en) | 2012-08-09 |
| KR20190025740A (en) | 2019-03-11 |
| CA2826262A1 (en) | 2012-08-09 |
| KR101954118B1 (en) | 2019-03-05 |
| CN105147533B (en) | 2018-07-31 |
| KR102156731B1 (en) | 2020-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012106551A1 (en) | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation | |
| IN2015DN02573A (en) | ||
| PH12014501561A1 (en) | Therapeutically active compounds and their methods of use | |
| EP2477985A4 (en) | Treatment of cancer | |
| IN2014DN09434A (en) | ||
| GB201118656D0 (en) | New compounds | |
| JO3091B1 (en) | Branched 3-phenylpropionic acid derivatives and their use | |
| UA113541C2 (en) | Substituted pyrrolidine-2-carboxamides | |
| MX349004B (en) | New compounds. | |
| PH12018500071B1 (en) | Plinabulin compositions | |
| IN2015DN01119A (en) | ||
| MY175800A (en) | Combination treatment of cancer | |
| IN2014DN06104A (en) | ||
| PH12016500136A1 (en) | Positive allosteric modulators of nicotinic acetylcholine receptor | |
| MX350719B (en) | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation. | |
| EA032271B9 (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
| BR112016029012A2 (en) | method of treating non-small cell lung cancer and / or small cell lung cancer using thienotriazolodiazepine compounds | |
| NZ624726A (en) | Methods for treating gout flares | |
| MX2015001488A (en) | Treating inflammation using serelaxin. | |
| MX354667B (en) | Methods for treating a stroke-related sensorimotor impairment using aminopyridines. | |
| WO2012006585A3 (en) | Use of interleukin-15 to treat cardiovascular diseases | |
| GB201022049D0 (en) | Methods | |
| WO2014015137A3 (en) | Compositions and methods for treating dysproliferative diseases | |
| WO2012112862A3 (en) | Treating mycobacterial infection with cu+/++ boosting therapeutics | |
| MD20140001A2 (en) | Positive allosteric modulators of nicotinic acetylcholine receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |